GSE179235 MEK NRAS inhibition 5 v 1 human up (Gene Set)

Analyze

Playbook Workflow Builder
Playbook Workflow Builder: Gene Set Enrichment

Perform Gene Set Enrichment with this gene set against Common Fund program's gene sets, identifying significant overlaps using a pre-built PWB workflow. Run the workflow with GSE179235_MEK_NRAS inhibition_5_v_1_human_up.

GeneSetCart
GeneSetCart

GeneSetCart helps you to fetch gene sets from various data sources, augment, combine with set operations, visualize and analyze these gene sets in a single session. Start a new session with GSE179235_MEK_NRAS inhibition_5_v_1_human_up.

CFDE-GSE
CFDE Gene Set Enrichment (GSE)

CFDE-GSE illuminates connections between the input gene set and various CF gene sets that overlap with the queried gene set. Query CFDE-GSE with GSE179235_MEK_NRAS inhibition_5_v_1_human_up.

Playbook Workflow Builder
Playbook Workflow Builder

The Playbook Workflow Builder helps you interactively construct workflows leveraging CFDE APIs without code. Start a new workflow with GSE179235_MEK_NRAS inhibition_5_v_1_human_up.

Results found

Linked to

 

Label

Description

 

Gene

long intergenic non-protein coding RNA 205

Gene

TP53 target 1

Gene

long intergenic non-protein coding RNA 667

Gene

STARD4 antisense RNA 1

Gene

solute carrier family 71 member 3, pseudogene

Gene

AMZ2 pseudogene 1

Gene

long intergenic non-protein coding RNA 2381

Gene

WAP four-disulfide core domain 21, pseudogene

Gene

UBA6 divergent transcript

Gene

MIR9-2 host gene

  • Gene

    long intergenic non-protein coding RNA 205



  • Gene

    long intergenic non-protein coding RNA 667


  • Gene

    STARD4 antisense RNA 1


  • Gene

    solute carrier family 71 member 3, pseudogene


  • Gene

    AMZ2 pseudogene 1


  • Gene

    long intergenic non-protein coding RNA 2381


  • Gene

    WAP four-disulfide core domain 21, pseudogene


  • Gene

    UBA6 divergent transcript


  • DISPLAY PER PAGE
    This repository is under review for potential modification in compliance with Administration directives.